Skip to main content
. 2015 Jan 13;47(4):765–773. doi: 10.4143/crt.2014.168
Variable Significance (p-value) Hazard ratio 95% CI for Exp(B)
Lower Upper
Routine follow-up for 5 yr < 0.001 0.28 0.22 0.35
Age > 40 yr < 0.001 0.62 0.49 0.78
Histologic grade I (vs. II/III) < 0.001 0.17 0.09 0.29
Staging I (vs. II/III) < 0.001 0.36 0.28 0.47
HR+ and HER2- (vs. others) < 0.001 0.59 0.48 0.73

CI, confidence interval; HR, hormone receptor; HER2, human epidermal growth factor receptor 2.